Dolby Laboratories (NYSE:DLB – Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Thursday, July 30th. Analysts expect the company to post earnings of $0.67 per share and revenue of $311.9590 million for the quarter. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Individuals can find conference call details on the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 5:00 PM ET.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm had revenue of $395.63 million during the quarter, compared to analysts’ expectations of $385.80 million. During the same period in the previous year, the company earned $1.34 EPS. Dolby Laboratories’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, analysts expect Dolby Laboratories to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Dolby Laboratories Trading Down 1.7%
NYSE DLB opened at $49.05 on Thursday. The company has a market capitalization of $4.64 billion, a PE ratio of 19.39 and a beta of 0.81. Dolby Laboratories has a twelve month low of $48.26 and a twelve month high of $77.00. The business’s 50-day moving average price is $52.56 and its 200 day moving average price is $59.12.
Dolby Laboratories Announces Dividend
Analyst Ratings Changes
A number of research analysts recently weighed in on DLB shares. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Thursday, June 11th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, June 15th. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $90.75.
Read Our Latest Analysis on Dolby Laboratories
Insider Activity at Dolby Laboratories
In other news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the transaction, the senior vice president directly owned 118,727 shares in the company, valued at approximately $6,316,276.40. This trade represents a 6.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $54.90, for a total transaction of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares of the company’s stock, valued at $4,425,104.70. The trade was a 3.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 47,458 shares of company stock worth $2,639,537. 37.93% of the stock is owned by company insiders.
Institutional Trading of Dolby Laboratories
Several institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp raised its position in Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the period. First Trust Advisors LP raised its stake in shares of Dolby Laboratories by 23.8% in the 4th quarter. First Trust Advisors LP now owns 1,880,528 shares of the electronics maker’s stock valued at $120,768,000 after acquiring an additional 361,871 shares in the last quarter. AQR Capital Management LLC grew its stake in Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after buying an additional 592,282 shares during the last quarter. Snyder Capital Management L P increased its position in Dolby Laboratories by 24.4% in the 4th quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock worth $91,648,000 after buying an additional 279,743 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Dolby Laboratories by 7.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,237,572 shares of the electronics maker’s stock worth $79,482,000 after purchasing an additional 87,645 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
